XML 20 R10.htm IDEA: XBRL DOCUMENT
v3.26.1

Accrued expenses and other current liabilities | 3 Months Ended
--- | ---
Mar. 31, 2026
Payables and Accruals [Abstract] |
Accrued expenses and other current liabilities | Accrued expenses and other current liabilities Accrued expenses and other current liabilities consisted of the following (in thousands):
| March 31, 2026 |  | December 31, 2025
Rebates, chargebacks and returns | $ | 144,524 |  |  | $ | 132,780 |
Clinical accruals | 34,677 |  |  | 40,945 |
Employee related expenses | 5,229 |  |  | 16,542 |
Contract manufacturing | 11,138 |  |  | 17,143 |
Interest accruals | 1,677 |  |  | 4,193 |
Commercial services | 3,156 |  |  | 2,349 |
Other accruals | 6,987 |  |  | 5,792 |
| $ | 207,388 |  |  | $ | 219,744 |
See Note 3. “Revenue” for a breakdown of rebates, chargebacks and returns. Clinical accruals primarily represent unbilled work undertaken by contract research organizations as part of the advancement of the Company's clinical programs.

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration